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Purpose: To describe a novel polymorphism in the γD-crystallin (CRYGD) gene in a Brazilian family with congenital
cataract.
Methods:  A  Brazilian  four-generation  family  was  analyzed.  The  proband  had  bilateral  lamellar  cataract  and  the
phenotypes were classified by slit lamp examination. Genomic DNA was extracted from peripheral blood and coding
regions and intron/exon boundaries of the αA-crystallin (CRYAA), γC-crystallin (CRYGC), and CRYGD genes were
amplified by polymerase chain reaction and directly sequenced.
Results: Sequencing of the coding regions of CRYGD showed the presence of a heterozygous A→G transversion at c.
401 position, which results in the substitution of a tyrosine to a cysteine (Y134C). The polymorphism was identified in
three individuals, two affected and one unaffected.
Conclusions: A novel rare variant in CRYGD (Y134C) was detected in a Brazilian family with congenital cataract. Because
there is no segregation between the substitution and the phenotypes in this family, other genetic alterations are likely to
be present.
Congenital cataract is characterized by the presence of an
opacification of the lens at birth or during the first decade of
life  [1-5].  If  untreated,  it  can  result  in  significant  visual
impairment and even blindness [1]. This condition remains a
leading cause of reversible childhood blindness in the world
[4].
There are several causes for congenital cataract including
metabolic disorders, infections during embryogenesis, gene
defects, and chromosomal abnormalities [4]. About 8%−25%
of congenital cataracts have hereditary etiology [4,6]. The
most common mode of inheritance is autosomal dominant
with high penetrance [4,7,8]. Inherited congenital cataracts
exhibit  a  high  interfamilial  and  intrafamilial  phenotypic
variability with a significant genotypic heterogeneity [1,4].
The water-soluble lens crystallin proteins (α-, β-, and γ-
crystallins) account for approximately 90% of the total lens
proteins and perform an important function in maintaining the
transparency of the lens [1,4,7,9-11]. α-Crystallins exhibit
chaperone-like activity and are present in high concentrations
in the lens [4,11]. β- and γ-Crystallins have two domains
composed  of  two  highly  stable  protein  structures  called
“Greek key” motifs [1,4,12]. The presence of α- and β-/γ-
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crystallins  within  the  lens  makes  their  encoding  genes
excellent  candidates  for  congenital  cataract,  with  several
mutations already described [1,4,11].
In the present study, the analysis of the αA-crystallin
(CRYAA),  γC-crystallin  (CRYGC),  and  γD-crystallin
(CRYGD) genes was performed in a large Brazilian family
presenting congenital cataract with phenotypic variability and
suggestive high genetic heterogeneity.
METHODS
The study protocols adhered to the tenets of the Declaration
of  Helsinki  and  were  approved  by  the  Research  Ethics
Committees  of  the  Faculty  of  Medical  Sciences  of  the
University of Campinas (Campinas, SP, Brazil). Appropriate
informed consent from each participant was obtained.
Patients and clinical data: A Brazilian family of four
generations (8 affected members and 30 unaffected members)
was  investigated  at  the  University  of  Campinas
Ophthalmology Department. Affected status was determined
by ophthalmic examination that included visual function, slit
lamp examination, measurement of intraocular pressure, and
fundus evaluation with dilated pupil. Cataract was classified
based on its characteristics present at slit lamp evaluation or
by the analysis of patients’ records who presented a history of
cataract  extraction.  Detailed  ocular,  medical,  and  family
histories were obtained from each available family member.
Individuals had no suggestive history of intrauterine infection,
unilateral cataract, and other ocular or systemic disorders.
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Eugênio Santana de Figueirêdo,1,2 Gabriel Gorgone Giordano,1 Anderson Tavares,2 Márcio José da Silva,2
José Paulo Cabral de Vasconcellos,1,2 Carlos Eduardo Leite Arieta,1 Mônica Barbosa de Melo2Fifty  subjects  without  diagnostic  features  of  congenital
cataract  were  recruited  as  normal  controls,  representing  a
sample of the Brazilian population.
Genomic  DNA  preparation  and  molecular  analysis:
Venous blood (5–10 ml) was collected for genomic DNA
extraction  and  subsequent  molecular  genetic  analysis.
Polymerase chain reaction (PCR) was used to amplify all the
exons  and  intron/exon  boundaries  of  the  candidate  genes
(CRYAA, CRYGC and CRYGD). The PCR cycling conditions
were: initial denaturation at 94 °C for 5 min followed by 35
cycles of 94 °C for 1 min, X °C for 1 min, 72 °C for 1 min,
and final extension at 72 °C for 7 min. Amplification of
samples was performed in a “Mastercycler EP Gradient S”
thermalcycler  (Eppendorf,  Hamburg,  Germany).
Oligonucleotide  primer  pairs,  PCR  product  sizes,  and
annealing  temperatures  are  described  in  Table  1.  PCR
products  were  electrophoresed  in  1.5%  agarose  gels
containing 0.05% ethidium bromide, purified, and submitted
to  direct  sequencing  on  the  ABI  PRISM  3700  Genetic
Analyzer automated sequencer (Applied Biosystems, Foster
City, CA). The sequencing reactions conditions were: 1 cycle
of 96 °C for 1 min 30 s and 24 cycles of 96 °C for 12 s, 50 °C
for 6 s, and 60 °C for 4 min, using Big Dye Terminator Ready
Reaction  v3.1  (ABI  PRISM  Big  Dye  Terminator  Cycle
Sequencing  Kit;  Applied  Biosystems).  Sequencing  results
were analyzed through submission to similarity search using
the “search algorithm” BLAST.
Computational  methods:  Algorithms  available  in  the
internet as automated methods were used as tools to evaluate
the possible influence of the substitution of an amino acid in
the protein function. Sorting Intolerant from Tolerant (SIFT)
amino acid substitutions assumes that the important amino
acids tend to be conserved between species. This method
assigns a substitution probability from 0 to 1 for each possible
amino acid change. Substitution with probabilities less than
0.05 are considered intolerant. Polymorphism Phenotyping 2
(PolyPhen-2) algorithm considers the conservation of amino
acids  between  species  and  physicochemical  differences
between wild and mutant proteins. The Align-GVGD method
is  based  on  chemical  differences,  polarity  and  molecular
volume between permuted amino acids. Scores range from 15
to 215, with scores >100 predictive of deleterious mutations
and tolerable <60.
RESULTS
Clinical  evaluation:  This  family  is  represented  by  four
generations of individuals. Four members were affected by
bilateral lamellar cataract, including the proband (III-19, IV-5,
IV-6, and IV-7). Four individuals had bilateral pulvurulent
cataract  (II-11,  III-6,  III-21,  and  III-22).  The  two  oldest
individuals of the family (I-1 and I-2) had nuclear and anterior
cortical lens opacities with characteristics of senility. One
patient with lamellar cataract underwent surgery at another
hospital, presenting bilateral aphakia and severe amblyopia in
his right eye. Three other individuals with lamellar cataract
were operated at 1, 12, and 18 months of age, respectively
(Figure 1). Visual acuity in this family subsequently to surgery
ranged from count fingers to 1.0 (Table 2).
Mutation analysis: Direct sequencing was performed to cover
exons and intron-exon boundaries of CRYAA, CRYGC, and
CRYGD. A heterozygous A→G transition was identified at c.
401 position of exon 3 in two affected members (III-22 and
IV-7) and in one unaffected member (II-15; Figure 2). This
alteration resulted in the missense substitution of a wild type
tyrosine to a cysteine (Y134C) in the CRYGD protein. The
variant was completely absent in 100 chromosomes of 50
unrelated controls. The other affected members showed no
alterations in any of the evaluated crystallins.
TABLE 1. PRIMERS FOR PCR AMPLIFICATION OF THE CRYAA, CRYGC, AND CRYGD GENES, PRODUCT SIZES, AND ANNEALING
TEMPERATURES.
Gene Exon Strand Sequence (5′→3′) Fragment Size
(bp)
T (°C)
CRYAA 1 sense CACGCCTTTCCAGAGAAATC 466 63.9
  1 antisense CTCTGCAAGGGGATGAAGTG    
  2 sense CTTGGTGTGTGGGAGAAGAGG 377 58.0
  2 antisense TCCCTCTCCCAGGGTTGAAG    
  3 sense CCCCCTTCTGCAGTCAGT 989 57.0
  3 antisense GCTTGAGCTCAGGAGAAGGA    
CRYGC 1 - 2 sense ACCAGAGAACAAGGACACAATC 674 66.6
  1 - 2 antisense TGGCTTATTCAGTCTCTGATG    
  3 sense ATTCCATGCCACAACCTACC 590 66.3
  3 antisense CCAACGTCTGAGGCTTGTTC    
CRYGD 1 - 2 sense CCCTTTTGTGCGGTTCTTG 596 54.0
  1 - 2 antisense TTTGTCCACTCTCAGTTATTGTGAC    
  3 sense TGTGCTCGGTAATGAGGAG 700 61.0
  3 antisense AGGCCAGAGAATCAAATGAG    
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a score of 0.00 to position Y134. The PolyPhen-2 algorithm
showed  a  score  of  1.000  and  the  Align-GVGD  method
presented a score of 193.72.
DISCUSSION
A considerable amount of mutations associated with human
congenital cataracts have been described in CRYGD [1,4,13].
These mutations alter the stability and/or the solubility of γ-
crystallins and contribute to loss of transparency of the lens
fibers  [1].  Therefore,  several  crystallin  genes  have  been
considered as candidates for hereditary congenital cataract
[4,6].
The autosomal dominant congenital cataract has a high
penetrance and is usually symmetric in affected individuals.
However,  there  may  be  considerable  variability  within  a
pedigree and between the two lenses of the same individual
[14-21]. This may explain the different phenotypes observed
in the family evaluated.
There are few studies about genetic alterations related to
congenital cataract in the Brazilian population. Santana et al.
[4] related the Y56X substitution in exon 2 of CRYGD in a
Brazilian family with the nuclear phenotype, resulting in a
truncated protein missing 118 amino acids. In the same study,
a mutation in exon 1 of CRYAA (R12C) was reported.
This study describes the Y134C substitution, located in
exon 3 of CRYGD, which, to our knowledge, was not reported
in  any  population  to  date.  The  effect  of  this  amino  acid
substitution was evaluated through Polyphen-2, SIFT, and
Align-GVGD computational programs. The results of in silico
analysis of these algorithms suggest that a variation Y134C in
CRYGD  tends  to  be  intolerant  as  evaluated  by  the  SIFT
method  that  revealed  a  score  of  0.00  to  position  Y134.
Furthermore, PolyPhen-2 achieved a score of 1.000, showing
that the amino acid tyrosine at this position is highly conserved
among species (Figure 2) as well as the physicochemical
differences  between  wild  and  mutant  proteins  indicate
“probably  damaging.”  Finally,  the  Align-GVGD  method
presented  a  score  of  193.72,  demonstrating  that  the
substitution  is  probably  deleterious  as  well.  Santana  and
colleagues  [4]  used  these  same  algorithms  to  analyze  the
R12C  mutation  in  CRYAA  which  was  segregating  with
congenital cataract in a Brazilian family. They found similar
scores to those obtained in this study.
The other mutation described by Santana and colleagues
[4], the Y56X in CRYGD, does not apply for the three in silico
methods due to generation of a truncated protein. Chan et al.
Figure 1. Pedigree of a four-generation family harboring congenital cataract. The proband is marked with an arrow. Squares and circles indicate
males and females, respectively. Black and white symbols denote affected and unaffected individuals, respectively. A slash through the symbol
means that the family member is deceased. Thirty-eight individuals (eight affected and thirty unaffected) from the family were enrolled and
underwent ophthalmic examinations and genetic analysis (individuals marked by an asterisk did not participate in the study).
TABLE 2. CLINICAL EVALUATION OF PATIENTS AFFECTED BY CONGENITAL CATARACT.
Individual Diagnostic
Age (years)
Phenotype Surgery BCVA OD BVCA OS Polymorphism
Y134C in
CRYGD
II-11 46 Pulvurulent No 1.0 1.0 No
III-6 24 Pulvurulent No 1.0 1.0 No
III-19 at birth Lamellar Yes CF 0.6 No
III-21 26 Pulvurulent No 1.0 1.0 No
III-22 25 Pulvurulent No 1.0 1.0 Yes
IV-5 at birth Lamellar Yes 0.4 0.5 No
IV-6 at birth Lamellar Yes 0.05 0.05 No
IV-7 at birth Lamellar Yes 0.4 0.3 Yes
            BCVA OD: Best corrected visual acuity in right eye. BCVA OS: Best corrected visual acuity in left eye. CF: Count fingers.
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combined, their isolated predictive value is increased.
Besides the analysis of these three algorithms suggesting
that the Y134C variant in CRYGD could be a causative disease
mutation and that it occurred in a gene already associated with
congenital cataract, the evaluation of its segregation pattern
within this family is not consistent with its relation to the
disease. The presence of this alteration in individuals II-15,
III-22, and IV-7 and its absence in the other family members
might indicate the occurrence of a de novo mutation. The fact
that individual III-21 is affected but does not have the same
variation as his brother as well as the presence of congenital
cataract in other family members without this variation (II-11,
III-6,  III-19,  IV-5,  and  IV-6)  indicates  that  other  gene  is
involved in the etiology and that the Y134C variant is a rare
SNP probably not associated with the disease.
There are six affected individuals who do not present the
substitution. Santana et al. [4] found a novel polymorphism in
CRYGC  (S119S)  in  a  family  with  bilateral  autosomal
dominant congenital nuclear cataract and microcornea that
was absent in some affected individuals. It was suggested that
this absence could be justified by recombination events and
that this polymorphism could be a marker of an unidentified
gene located in this region.
Isolated  autosomal  dominant  cataract  is  genetically
heterogeneous and to date 14 genes and nine additional loci
have  been  implicated  with  the  disease  [11,23].  The
manifestation of the disease in this family may be influenced
by  more  than  one  gene  with  incomplete  penetrance.
Additionally,the possible interaction with other genes, not
analyzed in this study, may have interfered with the Y134C
substitution  in  the  susceptibility  to  congenital  cataract
development.
In conclusion, we found a novel substitution in CRYGD
in a Brazilian family with congenital cataract in which there
is  no  accurate  segregation  with  the  disease,  hence,  it  is
probably not a disease causing mutation. Further studies in
this  family  involving  structural  and  functional  genes
associated with congenital cataract are necessary to better
understand the mechanisms underlying congenital cataract
development.
ACKNOWLEDGMENTS
The authors wish to acknowledge the members of the family
for their participation in this study.
REFERENCES
1. Yao K, Jin C, Zhu N, Wang W, Wu R, Jiang J, Shentu X. A
nonsense  mutation  in  CRYGC  associated  with  autosomal
Figure 2. Sequence analysis of CRYGD.
A: Sequence of a member without the
polymorphism.  B:  Heterozygous
polymorphism  detected  in  exon  3  of
CRYGD (individuals II-15, III-22, and
IV-7). C: Multiple sequence alignment
of the CRYGD protein (codons 120–
145) in different species, demonstrating
that residue 134 is highly conserved. D:
Slit-lamp  photograph,  showing
pulvurulent cataract in individual III-22
(left) and lamellar cataract in individual
IV-7 (right).
Molecular Vision 2011; 17:2207-2211 <http://www.molvis.org/molvis/v17/a239> © 2011 Molecular Vision
2210dominant congenital nuclear cataract in a Chinese family. Mol
Vis 2008; 14:1272-6. [PMID: 18618005]
2. Haddad MA, Sei M, Sampaio MW, Kara-Jose N. Causes of
visual impairment in children: a study of 3,210 cases. J Pediatr
Ophthalmol Strabismus 2007; 44:232-40. [PMID: 17694828]
3. Thylefors  B,  Negrel  AD,  Pararajasegaram  R,  Dadzie  KY.
Global data on blindness. Bull World Health Organ 1995;
73:115-21. [PMID: 7704921]
4. Santana A, Waiswol M, Arcieri ES, Vasconcellos JPC, Melo
MB. Mutation analysis of CRYAA, CRYGC, and CRYGD
associated with autosomal dominant congenital cataract in
Brazilian  families.  Mol  Vis  2009;  15:793-800.  [PMID:
19390652]
5. Marner  E,  Rosenberg  T,  Eiberg  H.  Autosomal  dominant
congenital cataract. Morphology and genetic mapping. Acta
Ophthalmol (Copenh) 1989; 67:151-8. [PMID: 2728866]
6. Messina-Baas OM, Gonzalez-Huerta LM, Cuevas-Covarrubias
SA. Two affected siblings with nuclear cataract associated
with a novel missense mutation in the CRYGD gene. Mol Vis
2006; 12:995-1000. [PMID: 16943771]
7. Beby F, Morle L, Michon L, Bozon M, Edery P, Burillon C,
Denis P. The genetics of hereditary cataract. J Fr Ophtalmol
2003; 26:400-8. [PMID: 12843900]
8. Scott MH, Hejtmancik JF, Wozencraft LA, Reuter LM, Parks
MM,  Kaiser-Kupfer  MI.  Autosomal  dominant  congenital
cataract. Interocular phenotypic variability. Ophthalmology
1994; 101:866-71. [PMID: 8190472]
9. Graw J. Cataract mutations and lens development. Prog Retin
Eye Res 1999; 18:235-67. [PMID: 9932285]
10. Wistow GJ, Piatigorsky J. Lens crystallins: the evolution and
expression of proteins for a highly specialized tissue. Annu
Rev Biochem 1988; 57:479-504. [PMID: 3052280]
11. Reddy MA, Bateman OA, Chakarova C, Ferris J, Berry V,
Lomas E, Sarra R, Smith MA, Moore AT, Bhattacharya SS,
Slingsby  C.  Characterization  of  the  G91del  CRYBA1/3-
crystallin protein: a cause of human inherited cataract. Hum
Mol Genet 2004; 13:945-53. [PMID: 15016766]
12. Blundell T, Lindley P, Miller L, Moss D, Slingsby C, Tickle I,
Turnell B, Wistow G. The molecular structure and stability
of the eye lens: x-ray analysis of gamma-crystallin II. Nature
1981; 289:771-7. [PMID: 7464942]
13. Santhiya ST, Soker T, Klopp N, Illig T, Prakash MV, Selvaraj
B, Gopinath PM, Graw J. Identification of a novel, putative
cataract – causing allele in CRYAA (G98R) in an Indian
family. Mol Vis 2006; 12:768-73. [PMID: 16862070]
14. He W, Li S. Congenital cataracts: gene mapping. Hum Genet
2000; 106:1-13. [PMID: 10982175]
15. Conneally PM, Wilson AF, Merritt AD, Helveston EM, Palmer
CG,  Wang  LY.  Confirmation  of  genetic  heterogeneity  in
autosomal  dominant  forms  of  congenital  cataracts  from
linkage  studies.  Cytogenet  Cell  Genet  1978;  22:295-7.
[PMID: 752489]
16. Bateman JB, Spence MA, Marazita ML, Sparkes RS. Genetic
linkage analysis of autosomal dominant congenital cataracts.
Am J Ophthalmol 1986; 101:218-25. [PMID: 3456204]
17. Salmon JF, Wallis CE, Murray AD. Variable expressivity of
autosomal  dominant  microcornea  with  cataract.  Arch
Ophthalmol 1988; 106:505-10. [PMID: 3355418]
18. Marner  E,  Rosenberg  T,  Eiberg  H.  Autosomal  dominant
congenital cataract. Morphology and genetic mapping. Acta
Ophthalmol (Copenh) 1989; 67:151-8. [PMID: 2728866]
19. Lund AM, Eiberg H, Rosenberg T, Warburg M. Autosomal
dominant congenital cataract; linkage relations; clinical and
genetic  heterogeneity.  Clin  Genet  1992;  41:65-9.  [PMID:
1544213]
20. Scott MH, Hejtmancik JF, Wozencraft LA, Reuter LM, Parks
MM,  Kaiser-Kupfer  MI.  Autosomal  dominant  congenital
cataract. Interocular phenotypic variability. Ophthalmology
1994; 101:866-71. [PMID: 8190472]
21. Basti S, Hejtmancik JF, Padma T, Ayyagari R, Kaiser-Kupfer
MI, Murty JS, Rao GN. Autosomal dominant zonular cataract
with sutural opacities in a four- generation family. Am J
Ophthalmol 1996; 121:162-8. [PMID: 8623885]
22. Chan PA, Duraisamy S, Miller PJ, Newell JA, McBride C, Bond
JP,  Raevaara  T,  Ollila  S,  Nyström  M,  Grimm  AJ,
Christodoulou J, Oetting WS, Greenblatt MS. Interpreting
missense  variants:  comparing  computational  methods  in
human disease genes CDKN2A, MLH1, MSH2, MECP2, and
tyrosinase  (TYR).  Hum  Mutat  2007;  28:683-93.  [PMID:
17370310]
23. Reddy MA, Francis PJ, Berry V, Bhattacharya SS, Moore AT.
Molecular genetic basis of inherited cataract and associated
phenotypes.  Surv  Ophthalmol  2004;  49:300-15.  [PMID:
15110667]
Molecular Vision 2011; 17:2207-2211 <http://www.molvis.org/molvis/v17/a239> © 2011 Molecular Vision
Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China.
The print version of this article was created on 11 August 2011. This reflects all typographical corrections and errata to the
article through that date. Details of any changes may be found in the online version of the article.
2211